Dyax Corp. (NASDAQ: DYAX) today announced financial results for the third quarter ended September 30, 2010. Dyax will host a webcast and conference call at 5 p.m. (ET) today to review the financial results and corporate progress for the...(
read more)
Dyax Corp. (NASDAQ:DYAX) announced after the close that the FDA’s Pulmonary-Allergy Advisory Committee voted in favor of approval of DX-88 for the treatment of acute attacks of...(
read more)